Michigan attorney tipped family about pharmaceutical companies' merger, SEC says
Why now
Thesis: Enforcement reminder on deal-related information handling
Catalyst to watch: Formal SEC charges or settlement
Main risk: Limited broader market impact
Why it matters
SEC insider-trading case around a pharma merger highlights enforcement risk for deal-related information leaks.
Related assets & topics
HealthcareSources
- googlenews · news.google.com · 2026-09-28 14:20 UTC